Erratum to DYRK1A suppression restrains Mcl-1 expression and sensitizes NSCLC cells to Bcl-2 inhibitors

• Yangling Li,
• Dongmei Zhou,
• Shuang Xu,
• Mingjun Rao,
• Zuoyan Zhang,
• Linwen Wu,
• Chong Zhang,
• Nengming Lin

Affiliations

Yangling Li

Department of Clinical Pharmacology, Hangzhou First People’s Hospital, Nanjing Medical University, Hangzhou 310006, China

Dongmei Zhou

Department of Clinical Pharmacology, Hangzhou First People’s Hospital, Nanjing Medical University, Hangzhou 310006, China

Shuang Xu

Department of Clinical Pharmacology, Hangzhou First People’s Hospital, Nanjing Medical University, Hangzhou 310006, China

Mingjun Rao

Institute of Pharmacology, College of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China

Zuoyan Zhang

School of Medicine, Zhejiang University City College, Hangzhou 310015, China

Linwen Wu

School of Medicine, Zhejiang University City College, Hangzhou 310015, China

Chong Zhang

School of Medicine, Zhejiang University City College, Hangzhou 310015, China

Nengming Lin

Department of Clinical Pharmacology, Hangzhou First People’s Hospital, Nanjing Medical University, Hangzhou 310006, China